India plans new vaccines complex
This article was originally published in Scrip
Executive Summary
India is setting up an integrated vaccines complex in Chengalpet near Chennai to manufacture a range of vaccines for use in its universal immunisation programme (UIP), and for export. The complex, being established by the public sector company Hindustan Latex, is expected to entail an investment of about Rs5 billion ($114.4 million).